Anti-inflammatory and Insulin-sensitizing Effects of Combined Pandanus amaryllifolius and Syzygium polyanthum Extracts in HFD-STZ Induced Diabetic Rats
DOI:
https://doi.org/10.35799/jbl.v16i1.66731Keywords:
Type 2 Diabetes Mellitus, Pandanus Amaryllifolius, Syzygium Polyanthum, Inflammation, Insulin Resistance, Pancreatic HistopathologyAbstract
Type 2 Diabetes Mellitus (T2DM) is a global health crisis characterized by insulin resistance and pancreatic -cell failure, largely driven by chronic low-grade inflammation. Elevated pro-inflammatory markers, particularly TNF- and IL-6, disrupt insulin signaling. While conventional oral hypoglycemics are effective, their long-term use is often hindered by adverse effects. Pandanus amaryllifolius and Syzygium polyanthum are polyphenol-rich medicinal plants with significant antioxidant potential. This study evaluates the in vivo efficacy of a combined ethanolic extract of these plants in reducing TNF-, IL-6, and HOMA-IR levels, alongside in silico validation of their bioactive compounds. An experimental posttest-only control group design was employed using HFD-STZ-induced male Wistar rats. Key parameters included blood glucose, HOMA-IR, inflammatory cytokines, and pancreatic histopathology. Molecular docking was conducted to analyze the interaction between bioactive compounds and glucose metabolism receptors. The combined extracts significantly suppressed systemic inflammation, marked by a substantial reduction in TNF- and IL-6. This correlated with improved insulin sensitivity and lower HOMA-IR values. Histopathologically, the 200 mg/kg BW dose showed the most significant recovery of the islets of Langerhans. In silico analysis confirmed that flavonoids like quercetin exhibit strong binding affinities to target proteins. The combination of P. amaryllifolius and S. polyanthum acts as a potent anti-inflammatory and insulin sensitizer, offering a promising adjuvant therapy for T2DM management.
References
Al-Hajj, N. M. A. (2016). Adjuvant and metabolic effect of Syzygium polyanthum on diabetic rats. International Journal of Pharmacology, 12, 61–70.
Alberti, K. G. M. M., & Zimmet, P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Diabetic Medicine, 15(7), 539–553.
Berman, H. M. (2000). Protein Data Bank. Nucleic Acids Research, 28(1), 235–242.
Chiabchalard A, Tencomnao T. Pandanus amaryllifolius extracts stimulate insulin secretion from pancreatic cell lines. BMC Complement Altern Med. 2010.
Dallak, M. (2011). Syzygium polyanthum (Wight) Walp: A review on its ethnobotany, phytochemistry and pharmacological profile. Journal of Medicinal Plants Research, 5(11), 2121–2127.
Federation, I. D. (2019). IDF Diabetes Atlas (9th ed.). IDF.
Gotto, A. M., & Moon, J. E. (2015). Management of dyslipidemia BT - Braunwald’s Heart Disease (10th ed.). Elsevier.
Harborne, J. B. (1998). Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis (3rd ed.). Chapman & Hall.
King, A. J. (2012). The use of animal models in diabetes research. British Journal of Pharmacology, 166(3), 877–894.
Kusuma, I. W. (2011). Biological activity and phytochemical analysis of Syzygium polyanthum (Wight) Walp. leaf extract. Natural Product Sciences, 17(3), 219–225.
Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods, 44(1), 235–249.
Matthews, D. R. (1985). Homeostasis model assessment: Insulin resistance and beta-cell function. Diabetologia, 28(7), 412–419.
Morris, G. M. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791.
Ningrum, A. (2015). Antioxidant and antidiabetic activities of Pandanus amaryllifolius leaves at different stages of maturity. Food Chemistry, 188, 32–40.
Organization, W. H. (2016). Global Report on Diabetes. WHO.
Othman, S. N. (2014). Pandanus amaryllifolius (Pandan wangi): A review of its ethnomedicinal uses, phytochemistry, and pharmacology. Journal of Pharmaceutical Sciences and Research, 6(12), 434–442.
Pickup, J. C. (2007). Inflammation and therapeutic targets in type 2 diabetes. Expert Opinion on Therapeutic Targets, 11(10), 1271–1281.
Ramadhan, R., & Phuwaputawat, S. (2017). Antidiabetic activity of Syzygium polyanthum (Wight) Walp. leaves extract in streptozotocin-induced diabetic rats. Journal of Pharmaceutical Sciences, 4(1), 20–25.
Sari, et al. Herbal synergies suppressing NF-kB pathway and HOMA-IR index. Int J Herb Med. 2023.
Soelistijo, S. A. (2015). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia 2015. PB PERKENI.
Sudjana. (2005). Metoda Statistika. Tarsito.
Szkudelski, T. (2001). The mechanism of alloxan and streptozotocin action in β-cells of the rat pancreas. Physiological Research, 50(6), 537–546.
Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461.
Wild S, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.
Zhang, M. (2015). TNF-α and IL-6 in the development of insulin resistance and type 2 diabetes. Journal of Diabetes Research, 2015, 1–11.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Selvia Meilinda, Hadyanto Lim, Endy Juli Anto, Jekson M Siahaan, Menang B Tarigan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright Notice
Jurnal Bios Logos is an open access journal and the article's license is CC-BY-NC. This license lets others distribute, remix, tweak, and build upon author's work, as long as they credit the original creation. Authors retain copyright and grant the journal/publisher non exclusive publishing rights with the work simultaneously licensed under a https://creativecommons.org/licenses/by-nc/4.0/ . And Authors can still use their work commercially.







